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Aeromonas species are ubiquitous bacteria in terrestrial and aquatic milieus. They are becoming renowned as enteric pathogens of
serious public health concern as they acquire a number of virulence determinants that are linked with human diseases, such
as gastroenteritis, soft-tissue, muscle infections, septicemia, and skin diseases. Proper sanitary procedures are essential in the
prevention of the spread of Aeromonas infections. Oral ﬂuid electrolyte substitution is employed in the prevention of dehydration,
and broad-spectrum antibiotics are used in severe Aeromonas outbreaks. This review presents an overview of emerging Aeromonas
infections and proposes the need for actions necessary for establishing adequate prevention measures against the infections.
1.Introduction
The aeromonads are Gram-negative, rod-shaped, facultative
anaerobic, nonspore forming bacteria that are autochtho-
nous and widely distributed in aquatic environments [1].
The genus is made up of psychrophiles and mesophiles
from soil and aquatic environments and causes diﬀerent
kinds of diseases to many warm and cold-blooded animals.
Several reconsiderations on the taxonomy and nomenclature
of Aeromonas genus have been carried out over the years
[2–4]. Although Aeromonas was initially positioned in
the family Vibrionaceae, successive phylogenetic analyses
point out that the genus Aeromonas is not closely related to
vibrios resulting in the relocation of Aeromonas from the
family Vibrionaceae to a new family, the Aeromonadaceae
[2, 5]. The aeromonads and Enterobacteriaceae share many
biochemical characteristics but are easily diﬀerentiated by
oxidasetestforwhichtheaeromonadsarepositive.Generally,
membersofthegenusarecharacteristicallydividedintothree
biochemically diﬀerentiated groups (Aeromonas hydrophila,
Aeromonas caviae, and Aeromonas sobria), and these contain
an u m b e ro fg e n o m o s p e c i e s ,a n dr e c e n t l y ,n e ws p e c i e sh a v e
been added [3, 6]. Currently, the genus comprises of 17
DNA hybridization groups (HGs) or genomospecies and 14
phenospecies [7].
Aeromonas species are known as causative agents of a
wide spectrum of diseases in man and animals [8]. Some
studies have shown that some motile Aeromonas species
are becoming food and waterborne pathogens of increasing
importance [9, 10]. They have been associated with several
food-borne outbreaks and are progressively being isolated
from patients with traveler’s diarrhea [11]. Presently, as a
putatively emerging enteric pathogen, Aeromonas species
have the inherent capability to grow in water distribution
systems,especiallyinbioﬁlms,wheretheymayberesistantto
chlorination[12].Also,A.hydrophilaislistedintheContam-
inant Candidate List, and Environmental Protection Agency
Method 1605 has validated its detection and enumeration in
drinking water system [13].
In 1968, von Graevenitz and Mensch reviewed 30 cases
of Aeromonas infections or colonization, which created
awareness on their recognition as human pathogens and2 The Scientiﬁc World Journal
suggested that some aeromonads may be associated with
gastrointestinal diseases. Aeromonas species are commonly
isolated from fecal sample of children under the age of
ﬁve years, whereas their isolation from other body sites
usually occurred in adult populations. Aeromonads are
known to cause severe diarrheal disease of short duration or
chronic loose stools in children, the elderly, or the immuno-
compromised individuals [1], and they have been implicated
in travelers’ diarrhea. The bacteria also cause cellulitis
or wound infections due of traumatic injury in aqueous
environment [14]. They also cause septicemia related to
underlying diseases such as leukemia, cancer, cirrhosis, and
various infections such as urinary tract infections, surgical
wound infections, meningitis, peritonitis, and endocarditis
[15]. Some predisposing factors for Aeromonas infection
includehepaticdiseases,diabetes,hematologicmalignancies,
hepatobiliary, and renal diseases [15].
Environmental source of Aeromonas pathogen involved
in gastrointestinal infection was ﬁrst reported by Holmberg
and coworkers [16]. It was presented as an epidemiological
study to backup the signiﬁcance of untreated well water
as a source of infection in patients with diarrheal disease.
Phenotypic identiﬁcation was relied upon before 1990s for
the identiﬁcation of Aeromonas, while several studies pub-
lished thereafter identiﬁed isolates to hybridization groups.
Hybridization groups containing virulence factors may be
found in environmental and foods samples, but aeromonads
will only cause gastroenteritis when their presence goes
beyondaninfectivedoseforavulnerablehost[17,18].Inthis
paper, we present a general overview of Aeromonas species in
the light of the increasing report of this group of bacteria as
emerging pathogens and their eﬀect on public health.
2. Taxonomy andClassiﬁcation
Aeromonads were divided into two major groups based
on physiological properties and host range until the late
1970s. Motile aeromonads grow at optimum temperature
of 35–37◦C and those predicted to cause human infections
were recognized to be A. hydrophila. Nonmotile aeromonad
which grows at 22–28◦C and causes infections in ﬁshes is
called Aeromonas salmonicida [14]. Phenotypic markers for
their diﬀerentiation include optimum growth temperature,
motility, production of indole, and elaboration of a melanin-
like pigment on tyrosine agar [7, 14]. Thereafter, the genus
Aeromonas has advanced with the addition of new species
and the reclassiﬁcation of preexisting taxa [19]. In the
past, Aeromonas species were placed alongside Vibrio species
and Plesiomonas shigelloides in the family Vibrionaceae.
However, genetic studies provide enough facts to support
the placement of aeromonads in a family of their own called
Aeromonadaceae [2].
The current classiﬁcation of the genus Aeromonas is
based on DNA-DNA hybridization and 16S ribosomal DNA
relatedness, and the genera of the family Aeromonadaceae
now include Oceanimonas, Aeromonas, Tolumonas (incertae
sedis), and Oceanisphaera,[ 7]. The existing genomospecies
and phenospecies within the genus Aeromonas a r ea sl i s t e di n
Table 1.
3.Aeromonas Species
The genus Aeromonas are made up of straight, coccobacil-
lary-to-bacillary Gram-negative bacteria with surrounding
ends measuring 0.3–1.0 × 1.0–3.5µm[ 7]. Most motile
strainsproduceasinglepolarﬂagellum,whileperitrichousor
lateral ﬂagella may be formed on solid media in some species
[27]. Aeromonas species are facultative anaerobic, catalase,
and oxidase positive, and chemoorganotrophic. They pro-
duce diverse kinds of extracellular hydrolytic enzymes such
as arylamidases, esterases, amylase, elastase, deoxyribonu-
clease, chitinase, peptidases, and lipase [14, 19]a n dg r o w
optimally at temperature ranges of between 22◦Ca n d3 5 ◦C,
b u tg r o w t hc a na l s oo c c u ra t0 – 4 5 ◦Ci naf e ws p e c i e s[ 8].
Some species, such as A. salmonicida strains, do not grow
at 35◦C[ 7]. All Aeromonas resist pH ranges from 4.5 to 9
but the optimum pH range is 5.5 to 9 and optimum sodium
chloride concentration range is 0 to 4% [28].
Aeromonas’ resistance to vibrostatic compound O/129
(150µg) and variable presence of ornithine decarboxylase
activities diﬀerentiates the genus from Plesiomonas and
Vibrio [14]. Other important distinguishing qualities include
their inability to grow in the presence of 6.5% sodium
chloride; ability to liquefy gelatin; inability to ferment i-
inositol;negativestringtest.Somephenotypiccharacteristics
include an inability to grow on thiosulfate citrate bile salts
sucrose agar, and ability of most but not all Aeromonas
species to ferment D-mannitol and sucrose [27]. The bio-
chemicalcharacteristicsofAeromonas speciesareasshownin
Table 2.
A number of aeromonads are pathogenic for humans,
and most human clinical isolates belong to hybridization
groups (HGs) HG-1, HG-4, HG-8, HG-9, HG-10, HG-
12, or HG-14 [14, 29]. The proportion of strains within
these hybridization groups (HGs) that are capable of causing
human disease is not well recognized. HG-2, HG-3, HG-
5, HG-6, HG-7, HG-11, HG-15, HG-16, and HG-17 are
isolated from the terrestrial or aquatic environment or
from unhealthy animals, and they are not regarded as
human pathogens [29]. Those capable of causing diseases in
human are associated with a variety of infections including
septicemia, meningitis, wound infections, peritonitis, and
hepatobiliary infections [6].
4. Occurrence of Aeromonas Species
Aeromonas species are found globally in surface water,
ground water, chlorinated drinking water, nonchlorinated
drinking water, bottled mineral water [5, 12, 30], and broad
range of foods [31]. They are found in the intestinal tract of
humans and animals, raw sewage, sewage eﬄuents, sewage-
contaminated waters, and activated sludge [32, 33].
4.1. Occurrence of Aeromonas in Aquatic Environment.
Aeromonas species have been found in chlorinated drinking
water supplies in several countries [34, 35], and typically of
densities less than 10cfu/mL in drinking water distribution
systems. They occur in distribution system bioﬁlms where
they may be protected from disinfection [12], and multipleThe Scientiﬁc World Journal 3
Table 1: Hybridization groups (genomospecies) and phenospecies of the genus Aeromonas.
DNA hybridiza-
tion group (HG) Type strain/Reference Genospecies Phenospecies Remarks
1∗ ATCC 7966 A. hydrophila A. hydrophila Isolated from clinical specimens
1∗ BCCM/LMG 19562 A. hydrophila subsp. dhakensis A. hydrophila subsp. dhakensis Isolated from clinical specimens
1∗ BCCM/LMG 19707 A. hydrophila subsp. ranae A. hydrophila subsp. ranae Pathogenic for frogs
2∗ ATCC 14715 A. bestiarum A. hydrophila-like Isolated from clinical specimens
3∗ ATCC 33658 A. salmonicida A. salmonicida subsp.
salmonicida Nonmotile ﬁsh pathogen
3∗ ATCC 33659 A. salmonicida A. salmonicida subsp.
achromogenes Nonmotile ﬁsh pathogen
3∗ ATCC 27013 A. salmonicida A. salmonicida subsp.
masoucida Nonmotile ﬁsh pathogen
3∗ ATCC 49393 A. salmonicida A. salmonicida subsp. smithia Nonmotile ﬁsh pathogen
3∗ CDC 0434-84, Popoﬀ
C316 unnamed A. hydrophila-like Isolated from clinical specimens
4∗ ATCC 15468 A. caviae A. caviae Isolated from clinical specimens
5A∗ CDC 0862-83 A. media A. caviae-like Isolated from clinical specimens
5B∗ CDC 0435-84 A. media A. media
6∗ ATCC 23309 A. eucrenophila A. eucrenophila
7∗ CIP 7433, NCMB 12065 A. sobria A. sobria
8X∗ CDC 0437-84 A. veronii A. sobria
8Y∗ ATCC 9071 A. veronii A. veronii biovar sobria Isolated from clinical specimens
9∗ ATCC 49568 A. jandaei A. jandaei Isolated from clinical specimens
10∗ ATCC 35624 A. veronii biovar veronii A. veronii biovar veronii Isolated from clinical specimens,
ornithine decarboxylase positive
11∗ ATCC 35941 unnamed Aeromonas spp. (ornithine
positive)
12∗ ATCC 43700 A. schubertii A. schubertii Isolated from clinical specimens
13∗ ATCC 43946 Aeromonas Group 501 A. schubertii-like Isolated from clinical specimens
14∗ ATCC 49657 A. trota A. trota Isolated from clinical
15∗ ATCC 51208, CECT
4199 A. allosaccharophila A. allosaccharophila
16∗ ATCC 51020, A. encheleia A. encheleia Pathogenic for eels
17∗ BCCM/LMG 1754 A. popoﬃiA . p o p o ﬃi
Unassigned∗ MTCC 3249, NCIM
5147 A. culicicola A. culicicola Isolated from mosquitoes
Unassigned [20] A. eucrenophila A. tecta Isolated from clinical and
environmental sources
Unassigned [21] A. trota A. aquariorum Isolated from monkey faeces
Unassigned [22] A. popoﬃi A. bivalvium Isolated from aquaria of
ornamental ﬁsh
Unassigned [23] unnamed A. sharmana Isolated from bivalve molluscs
Unassigned [24] A. encheleia A. molluscorum Isolated from bivalve molluscs
Unassigned [25] A. schubertii A. simiae Isolated from midgut of
mosquitoes
Unassigned [26] A. jandaei A. culicicola Isolated from a warm spring
∗Carnahan and Joseph [7].
strains are frequently found in water sources [36]. In the
Netherlands, a drinking water standard of 200cfu/100mL at
25◦C has been established for Aeromonas [37].
Maalej and colleagues [38] studied seasonal distribution
of Aeromonas populations in urban eﬄuent and natural
seawater. They found 1.48 × 105 to 2.2 × 108 cfu/100mL
in the eﬄuent, while seawater had counts lower than the
detection limit to 7.9 × 103 cfu/100mL, and the seasonal
abundanceofAeromonas wasinverselyrelatedtotheseasonal
density of fecal coliforms.4 The Scientiﬁc World Journal
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Bonadonna etal.[39] studied theincidence of bacteriaof
anthropomorphic origin and those of autochthonous origin
using model systems for prediction of public health risk
to marine bathers. The resulting model used salinity, total
coliforms, fecal coliforms, Escherichia coli,a n dl o c a t i o na s
analytical variables for presence of aeromonads. In the study,
the presence of Escherichia coli and fecal coliforms were
associated with lower Aeromonas counts, while prevalence
of total coliform was associated with higher Aeromonas
densities. Fecal coliforms and high salinity was associated
with higher Aeromonas population. The complexity of the
relationship between anthropomorphic and autochthonous
bacteria confounds development of a predictive models for
estimating public health risk of recreational exposure to
marine waters.
4.2. Occurrence of Aeromonas in Food. Aeromonads have
been isolated from food animals like ﬁsh, shellﬁsh, meats,
dairy products, and fresh vegetables. However, only few food
borne outbreaks have been documented [28]. In a survey of
all foods of animal origin carried out in India, aeromonads
was isolated from ﬁsh (22%), snails (6.25%), and quail eggs
(18%), buﬀalo milk (2.8%), and goat meat 8.9% [40]. These
ﬁndings were in agreement with those of Tsai and Chen
[41], who reported aeromonads in 22.2% of ﬁsh samples.
Abbey and Etang [42] reported isolation of aeromonads
in 28-29% of snails in Nigeria. Igbinosa and colleagues
[43] also reported incidence of Aeromonas from some food
samplesincludingvegetablesamples(35%),freshﬁsh(67%),
smoked ﬁsh (70%), shrimps (60%), poultry (80%), meat
(54%), meat products (80%), and raw milk (85%) in Benin
City, Nigeria. Neyts et al. [18] reported the presence of
Aeromonas species in densities of <2log10 to >5log10 cfu/g
in 26% of vegetable samples, 70% of meat and poultry
samples, and 72% of ﬁsh and shrimp samples in 68 food
samples.
4.3. Occurrence of Aeromonas in Animal. The isolation of
Aeromonas species from diseased ﬁsh, turtles, alligators,
snakes, and frogs was the ﬁrst implication of Aeromonas as
animal pathogens [44]. A. salmonicida and A. hydrophila
cause furunculosis, ulcerative disease, hemorrhagic disease,
red sore disease, and septicemia in ﬁsh [45]. Lehane and
Rawlin [46] investigated zoonoses acquired from ﬁsh and
reported that aeromonads caused cellulitis, myositis, and
septicemia as a result of injuries from handling ﬁsh, working
in aquaculture, or keeping ﬁsh as pets. Also, Aeromonas
species have long been recognized as pathogens of amphib-
ians and reptiles [47].
A. hydrophila have been isolated from feces of normal
horses (6.4%), pigs (9.6%), sheep (9.0%), and cows (21.1%)
[48]. The total fecal carriage rate in animals is slightly
higher than that in normal humans, which is <1t o7 %
for most studies, although some studies report higher rates
[49]. Figura and Marri [50] isolated Aeromonas species from
the feces of domestic animals and found higher frequency
of A. hydrophila than A. caviae.S t e r ne ta l .[ 51] isolated
aeromonads from 3 of 21 turkeys and 1 of 32 cows, but none
was detected from 22 pigs and 24 sheep. Gray and Stickler
[52] reported ﬁndings of A. hydrophila predominantly in
cow feces and A. caviae in pig feces. Also, Hathcock et al.
[53] reported the isolation of Aeromonas species from feces,
bedding, and drinking water of healthy cows and pigs.
Foods of animal origin including contaminated ani-
mals may play signiﬁcant roles in the transmission of the
aeromonads from food or animals to humans and animal
feces appear to be the major source of contamination of
foods.Aeromonadshaverecurrentlybeenisolatedfrommeat
and edible organs of sheep and poultry, ﬁsh and seafood, raw
milk, red meats, as well as pork and beef [54]. A. hydrophila
was also isolated from diseased cyprinid loach in Korea [55].
The presence of aeromonads in food of animal origin may
pose a public health problem for humans who come in
contact with such animals.
4.4. Occurrence of Aeromonas in Human. Humans carry
Aeromonas species in their gastrointestinal tract both in
symptomatic and asymptomatic individuals. The rates of
faecal carriage in persons in the absence of disease in
developed countries range from 0% to 4% [56], while the
isolation rate frompersons withdiarrheal illness rangesfrom
0 . 8t o7 . 4 %[ 57].
Sinha et al. [58] reported aeromonads in 6.5% of all
patients in India, while in Hong Kong, Chan et al. [59]
documented aeromonads in 6.9% of adult patients with
acute diarrhoea. Others reported isolation rates from symp-
tomatic patients from 0.04% to 21% [60, 61]. In Limpopo
Province of South Africa, Obi and Bessong [62]r e p o r t e d
the isolation of Aeromonas sp. from 13.3% HIV patients
with chronic diarrhoea in rural communities. Immunocom-
promised people can also suﬀer from Aeromonas-associated
chronic diarrhoea. In Saudi Arabia, Ibrahim and Colleagues
[63] reported two cases of chronic colitis from immunocom-
promised patients associated with A. hydrophila.
5. Pathogenesis andVirulence Factors
Aeromonas species produces a broad range of extracellular
enzymes, some of which are thought to contribute to patho-
genesis. Virulence of aeromonads depends on several factors
and also incompletely understood despite decades of intense
research [64]. Aeromonas is said to be pathogenic because
it possess all the requirements of pathogenic bacteria. It
attaches and enters into host cells through production
of ﬂagella, pili and adhesins [65]. Multiplication in host
tissue is assisted by the production of siderophores and
outer membrane proteins, while production of capsule, S-
layer, lipopolysaccharide, and porins contributes to their
resistance to host defenses mechanism. Enterotoxins, pro-
teases, phospholipases, and hemolysins cause damage to
host cells leading to cell death [65]. Several extracellular
products are elaborated, including cytotoxic and cytotonic
enterotoxins, hemolysins, and various hydrolytic enzymes.
T h eo c c u r r e n c eo fb o t hT y p eI Ia n dT y p eI I Is e c r e t i o n s
systems has been demonstrated [66], including the presence
of several virulence factors such as enolase.6 The Scientiﬁc World Journal
Some aeromonads produce a range of cell surface and
secretory proteases that may augment their virulence [67].
It is well documented that a signiﬁcant proportion of the
A. hydrophila isolated from chlorinated and nonchlorinated
water contained genes responsible for enterotoxigenic or
cytotoxic activity [68]. Also, environmental temperature
has been reported to be a parameter in the expression of
virulence factors. A. hydrophila isolated from the environ-
ment produced signiﬁcantly less enterotoxins when grown at
37◦Cc o m p a r e dt o2 8 ◦C, while the clinical isolates examined
produced more enterotoxins at 37◦C than at 28◦C[ 69].
The temperature of the human body is approximately 37◦C;
therefore, strains that produce virulence factors at this
temperature are likely to be more signiﬁcant as human
pathogens.
6. ClinicalInfections
Clinical indications of Aeromonas infection usually depend
upon the site and severity of infection [70]. Wound infec-
tions often result in cellulitis and rarely necrotizing fasciitis.
Septicemia may accompany wound infection or may be
secondary to systemic diseases such as cirrhosis, cancer,
biliary disease, diabetes, or diseases resulting in gastrointesti-
nal perforations [71], and dissemination may give rise to
meningitis or endocarditis. Pneumonia is infrequent and it is
usually associated with aspiration, such as in near drowning
[72]. Gastroenteritis symptoms vary from mild self-limiting
to dysentery or cholera-like illness. Both gastrointestinal
and extraintestinal infections are now known to occur in
previously healthy hosts as well as immunocompromised or,
otherwise, susceptible individuals [15].
6.1. Gastrointestinal Infection. Aeromonas species have in-
creased in recent years since they cause gastroenteritis,
cellulitis, peritonitis, meningitis, and pneumonia in im-
munocompromised humans and disseminated infections in
immunocompromised hosts [11]. In developing countries,
A. hydrophila is also known to cause diarrhea in children
[73]a n dt r a v e l e r s[ 74]. Known risk factors that predispose
humans to the disease include drinking or swimming in
contaminated water and also ingestion of contaminated
food.
Though Aeromonas species have been recognized as
entericpathogens,theirmechanismsofpathogenicityremain
vague. A. caviae bind to mucosal epithelial cells [35], and
the majority of aeromonads related to gastroenteritis include
A. veronii biovar sobria (HG-8/10), A. hydrophila (HG-1),
and A. caviae (HG-4), though A. veronii biovar veronii (HG-
8/10), A. trota (HG-13), and A. jandaei (HG-9) occur rarely
[11].GastroenteritisattributedtoA.sobriawascharacterized
by acute watery, abdominal pain, vomiting, diarrhea, and
fever [70]. Goldsweig and Pacheco [75] also reported on
infectious colitis caused by Aeromonas species.
6.2. ExtraIntestinal Infection. Extraintestinal infections of
environmental origins arise directly from soil or water con-
tact, or indirectly by ingestion and bacteremic dissemination
of aeromonads from the gastrointestinal tract [11]. The two
major routes of infection are environment-water-animals
complex and ingestion of contaminated foods [71].
In immunocompromised persons, bone infections
appear to be a result of blood-borne spread [15]. In healthy
persons, bone infection is next to tissue trauma, often arising
after contamination in freshwater [14]. Invasive infections
at other sites occur primarily in immunocompromised
patients, particularly those with leukemia, malignancy,
cirrhosis of the liver, or immunosuppression cases [15].
In cases of Aeromonas septicemia diﬀerent from those of
soft-tissue infections, the origin of the organism and portal
of entry is yet unclear. An endogenous source has been
proposed as the locus of infection from which subsequent
bloodstream invasion arises [72].
7. Epidemiology and Disease
OutbreakinAeromonas
Aeromonads are commonly isolated from drinking water
[12, 30], and temporal and seasonal relationship between
presenceof aeromonads in drinking waterand their presence
in the stools of patients with gastroenteritis have been
reported [11]. Yamada et al. [76] reported incidence of
Aeromonas infections in Japanese travelers to developing
countries. Aeromonas species have been reported as the cause
of diarrhea in 2% of travelers to Africa, Latin America and
Asia [77, 78]. Human carriage of Aeromonas species could be
symptomatic or asymptomatic. In developed countries, the
rates of fecal carriage in asymptomatic persons range from
0% to 4% [34], while the isolation rate from individuals with
diarrheal illness ranges from 0.8 to 7.4% [35] .T h er a t eo f
recovery among children with diarrhea vary geographically:
0.62to4%wasreportedinMalaysia[79];2%inSweden[34];
0.75% in Nigeria [80]; 4.8% in Switzerland [81]; 2.3% in
Taiwan [82]; and 6.8% in Greece [83]. In India, aeromonads
was reported in 6.5% of all patients [36]. Chan et al. [37]
also documented the incidence of aeromonads in 6.9% of
adult patients with acute diarrhea in Hong Kong. Previous
reports on incidence rates from symptomatic patients range
from 0.04% to 21% [38, 39]. Generally, the isolation rates
in human fecal specimens vary as geographical areas, food
habits, level of sanitation, patient populations, and isolation
methods aﬀects the recovery rates [38].
8.DiagnosisandDetectionof
Aeromonas Species
To detect outbreaks eﬃciently, public health surveillance,
and diagnostic procedures for Aeromonas species require
both sensitivity and speciﬁcity. The approaches of Abbott
et al. [4] and Carnahan and Joseph [7] make it possible to
identify nearly every isolate to species levels.
8.1. Culture-Based Detection Methods. Aeromonads grow
on isolation media, and a huge number of selective and
diﬀerential isolation media have been developed for the
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and clinical specimens [84]. Comparative study suggest
that no single medium results in optimum recovery of
aeromonads, and combinations of diﬀerent isolation media
and methods are frequently employed by direct plating,
membrane ﬁltration, or multiple tube tests for determining
most probable numbers. The membrane ﬁltration method,
EPA Method 1605, has been authenticated for the isolation
of A. hydrophila from drinking water samples [13].
Several culture enrichment and culture media have been
evaluated for the recovery of aeromomads from foods
[31]. Starch ampicillin agar (SAA) and bile salts inositol
brilliant green agar (BIBG) with initial enrichment in
alkaline peptone water (APW) or tryptose broth containing
ampicillin (TSB-30, ampicillin 30mg/L) are recommended
simultaneously with commercially available media such as
Aeromonas Medium (Ryan’s Medium). Starch glutamate
ampicillin penicillin (SGAP-10) medium wasused in the iso-
lation of aeromonads from sewage sludge [85]. This medium
is highly selective, and it has been used to detect aeromonads
from foods and other samples matrices. Aeromonas species
grow readily in blood culture media and on 5% sheep blood
agar used in clinical laboratories for detection and isolation
of human pathogens from normally sterile body sites [31].
Isolation of aeromonads from contaminated samples such
as feces require the use of selective and diﬀerential media
suchasMcConkeyagar,cefsulodinirgasannovobiocin(CIN)
agar, or blood ampicillin agar (10mg/L ampicillin). To
facilitate recovery of aeromonads from highly contaminated
samples such as feces, enrichment broths such as alkaline
peptone water are incubated overnight and subcultured
onto CIN agar and blood ampicillin agar [85]. Culture
plates are then incubated aerobically at 35◦C for 24–48h.
Aeromonas species produce distinctive colonies, with or
without hemolysis on blood agar. Colonies are screened by
carrying out oxidase test and identiﬁed using biochemical
methods or commercially-available bacterial identiﬁcation
kits [13, 85].
8.2. Molecular Detection and Identiﬁcation Methods. Poly-
merase chain reaction (PCR) methods have been developed
to detect the presence of Aeromonas species in a wide range
of samples. ¨ Ozbas et al. [86] developed a PCR method for
the detection of A. hydrophila in raw milk. The detection
limit was 2log10 cfu/g and the detection rate was 23% for
PCR method and 14% for culture method. Stine et al.
[87] constructed a microarray of DNA probes to study the
populationdynamicsofmicrobialcommunitiesandusedthe
microarray to study population dynamics and interactions
of marine bacteria in coastal waters where aeromonads were
found to make up a large proportion of the microbial ﬂora.
Galindo and coworkers [88, 89] also used microarrays to
detect A. hydrophila cytotoxic enterotoxin-inducing genes
in macrophages, thus revealing the potential of microarrays
in elucidating intracellular mechanisms of pathogenesis.
Galindo et al. [90] used microarrays and proteomics to
examine the eﬀects of cytotoxic enterotoxin on human
epithelial cells.
Someresearchershavedevelopedprobesforthedetection
of various Aeromonas species [91, 92]. Jun et al. [55]
employed the restriction fragment length polymorphism
(RFLP) method to distinguish A. salmonicida and A. bes-
tiarum. The genetic heterogeneity of aeromonads as the
result of crossover in ribosomal sequences makes it unlikely
that 16S ribosomal DNA will be a practical means of dif-
ferentiation of species [93], since additional endonucleases
must be added as new species are recognized, resulting in an
unwieldy and overly complex typing system [94, 95].
The 16S-23S intergenic spacer regions were sequenced,
and it was found that the resulting phylogeny did not
agree with the results of 16S ribosomal DNA and DNA-
DNA hybridization studies [96]. The sequence analysis of
the gyrB gene was used to construct a phylogenetic tree of
all 17 hybridization groups [97]a n dAeromonas culicicola
was grouped with Aeromonas veronii, but it grouped with
Aeromonas jandaei basedupon16Sribosomalgenesequence.
The sequence analysis of the polymerase chain reaction
amplicons of the gyrB gene was viewed as a better phylo-
genetic chronometer than the 16S ribosomal gene. Yanez et
al. [98] have documented that the gyrB gene agree with the
16S ribosomal data which led to placement of the genus
Aeromonas in the family Aeromonadaceae,a n dgyrB gene
sequences were useful in resolving discrepancies between
16S ribosomal gene sequences and DNA-DNA hybridization
results.
Minana-Galbis et al. [99] also examined the genetic
diversity among A .h y d r o p h i l a ,A .b e s t i a r u m ,A .s a l m o n i c i d a
and Aeromonas popoﬃi by multilocus enzyme electrophore-
sis (MLEE). Aeromonas popoﬃi and A. bestiarum were found
to be closely related this method. MLEE has been used in
genomospecies determination since 1991 [100]. Multilocus
sequence typing (MLST) using the four gene loci of 16S
rDNA, recA, gyrB, and chiA has revealed the taxonomic
limitations of 16S rDNA alone [101].
9. Prevention and Treatment
As highlighted previously, aeromonads are ubiquitous in
many environmental waters. As a result, they are present in
most source waters used for drinking water production. The
existing techniques used for treatment and disinfection are
eﬀective in minimizing the level of aeromonads in the ﬁn-
ished drinking water. It has been reported that A. hydrophila
is usually more susceptible to chlorine and monochloramine
than coliforms [12]. The most eﬃcient approach for con-
trolling Aeromonas growth is to limit the Aeromonas species
entering the distribution system through eﬀective treatment
and maintenance, to maintain temperatures below 14◦C, to
provide free-chlorine residuals above 0.1–0.2mg/L, and to
limit the levels of organic carbon compounds in the water
[102].However,itisdiﬃculttomanageitsgrowthinbioﬁlms
[12, 102].
Rehydration therapy is adequate intervention in most
pediatric cases of gastroenteritis and watery diarrhea caused
by Aeromonas species [102]. Draining obstructions and
antibiotic therapy are eﬀective in the management of
infection in patients with acute suppurative cholangitis
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of necrotizing fasciitis. In addition, cellutis may require
debridement, and abscesses may require draining [103].
Gastrointestinal infections caused by aeromonads are
generally self-limiting, and antibiotic therapy is required
only in prolonged cases in immunocompromised hosts.
Antimicrobials are employed for only severe and unrespon-
sive cases of Aeromonas gastroenteritis [103] or extraintesti-
nal infections [71, 73].
Aeromonas species demonstrate diﬀerences in their sus-
ceptibilities to antibiotics. Clinical isolates of A. caviae
are more susceptible to ticarcillin than A. veronii and A.
hydrophila. Use of clavulanic acid with amoxicillin enhances
antibacterial activity but tazobactam did not enhance the
eﬀect of piperacillin and A. veronii (79%) showed higher
susceptibility to cefazolin than A. caviae (53%) or A.
hydrophila (40%) [104].
Ko et al. [105] have established that minocycline and
cefotaxime administered simultaneously produced a syner-
gisticeﬀectagainstA.hydrophilausingamurinemodel.Also,
ciproﬂoxacin was as eﬀective as cefotaxime-minocycline in
vitro and in a murine model, suggesting that clinical studies
are necessary [106].
10.AntimicrobialResistance
The origins of antibiotic resistance in the environment
is relevant to human health because of the increasing
importance of zoonotic diseases as well as the need for
predicting emerging resistant pathogenic organisms [107].
Antibiotic-susceptibility pattern is also signiﬁcant for selec-
tive isolation of microorganisms. The aeromonads have been
regarded universally to exhibit resistance to the penicillins
(penicillin,ampicillin,carbenecillin,andticarcillin)forquite
al o n gt i m e[ 108]. In addition to selection of antibiotic
therapy in the clinical setting, antibiotic sensitivity pat-
terns are sometimes useful as phenotypic characteristics for
species identiﬁcation, especially for clinical isolates [108].
Most of Aeromonas species show susceptibilities to amino-
glycosides, tetracycline, chloramphenicol, trimethoprim-
sulfamethoxazole, and quinolones [108]. They are also
susceptible to piperacillin, azlocillin, and the second and
third generation of cephalosporins [108]. Sen and Rodgers
[36] reported antibiotic susceptibility tests on 164 strains
of Aeromonas, and resistance to nalidixic acid (54–62%),
ciproﬂoxacin (12–22%), and norﬂoxacin (14–19%) were
observed.
In the United States, over 90% of aeromonad strains
were susceptible to third-generation cephalosporins and
aminoglycosides and almost all the aeromonads were sus-
ceptible to quinolones [109]. Also, in the United States,
most strains were susceptible to chloramphenicol, tetra-
cycline, minocycline, doxycycline, and nitrofurantoin, but
resistant to vancomycin, clindamycin, and erythromycin.
Imipenem was reported to be eﬃcient for treatment of
Aeromonas infections [110]. Petersen and Dalsgaard [111]
found that most of their Aeromonas strains were resistant
to the commonly used antibiotics such as chloramphenicol,
tetracycline, and trimethoprim. Huys et al. [112]f o u n d
oxytetracycline-resistant Aeromonas strains in water from
ﬁsh farms and in hospital sewage.
The use of antibiotics in aquaculture plays an important
role in the ampliﬁcation of resistance in a given reservoir.
Multiple antibiotic resistances (MARs) between Aeromonas
species have been reported globally by diﬀerent authors
[36, 113, 114]. Radu et al. [115] reported the frequent
occurrence of multiple antimicrobial resistances and the
presence of similar resistance patterns in some A. hydrophila,
A. veronii biovar sobria,a n dA. caviae strains isolated from
ﬁsh. Most of the A. salmonicida strains isolated by Kirkan
and colleagues [116] were resistant to erythromycin, amoxy-
cillin+clavulanic acid, penicillin, gentamicin, oxytetracycline
cefuroxime sodium, and sulphamethoxazole+trimethoprim.
A. hydrophila isolated from ﬁsh samples in Mhow city,
India, showed 100% sensitivity to ciproﬂoxacin, cefuroxime,
ceftriaxone, cephotaxime, chloramphenicol, gentamycin,
kanamycin, nitrofurantoin, nalidixic acid, and oﬂoxacin,
while 62.2% and 50% of the bacteria were susceptible to
cotrimoxazoleandoxytetracycline,respectively.Ontheother
hand, all isolates were resistant to colistin and ampicillin
[113].
Resistance to chloramphenicol is very rare in Aeromonas
species. Michel et al. [117] reported that minimum
inhibitory concentrations (MICs) of chloramphenicol
against A. salmonicida strains displayed a bimodal distri-
bution and demonstrated the existence of a large and well-
delineated resistant population. Distribution of MIC values
of chloramphenicol in A. salmonicida strains were 0.25–
2µg/mL and 16–>256µg/mL, whereas in motile aeromonads
it ranged from 0.06µgmL −1 to >256µg/mL. Conversely, Guz
and Kozi´ nska [118] ﬁndings revealed that Aeromonas species
are susceptible to chloramphenicol (MIC >0.06–2mg/L,
MIC90 0.5mg/L). Chloramphenicol is hazardous to humans,
it causes an idiosyncratic, aplastic anemia, and at present, it
is extremely illegal to use in food animals.
Edwards and coworkers [119] documented antibiotic
resistance in Aeromonas species isolated from a eutrophic
lake in England. Go˜ ni-Urriza and colleagues [32, 120]
reported antibiotic resistance to trimethoprim (42%),
pipemidic acid (67%), streptomycin (65%), cephalothin
(93%), cefoxitin (56%), ticarcillin (87%), sulfamethoxazole
(90%), naladixic acid (59%), ampicillin (99%), oxolinic acid
(67%), and tetracycline (14%) in Aeromonas species isolated
from European rivers. Susceptibility to ﬂuoroquinolones
diﬀer from 54% to 98%. Most strains were susceptible
to ciproﬂoxacin, fosfomycin, colistin, gentamicin, cotri-
moxazole, cefotaxime, chloramphenicol, tobramycin, and
imipenem [120], and urban wastewater eﬄuents are thought
to be a contributing factor to the increasing rate of antibiotic
resistance in environmental aeromonads [120].
11. Public Health Control
The prevention of the spread of Aeromonas strains involved
in diarrhea depends on ensuring appropriate sanitary
measure like proper food preparation, hand-washing, and
eﬃcientsewagedisposalsystem.Propersurveillanceofwater,The Scientiﬁc World Journal 9
food, and sanitation facilities, using public health diagnostic
and detection procedures is essential to protect individuals
including infants from Aeromonas strain diarrhea.
In the aquaculture environment, management consists
of disposal of diseased animals and water treatment to
control the densities of aeromonads in aquaculture systems.
Maintaining high standards of water quality, temperature
control, disinfection of equipment, and stress reduction
reduce the prevalence of disease [102]. In aquaculturesystem
the quality of the water is of paramount importance in
the prevention of contamination of ﬁsh or plants grown in
wastewater ponds. Reliance has been placed principally on
minimizing the risk of pathogen transmission by thorough
cooking of the products, but this approach has not always
been satisfactory and, where the pond products are eaten
uncooked, no health protection is provided. Therefore, the
presence of potentially pathogenic and multidrug-resistant
Aeromonas strains in surface waters remains of signiﬁcant
healthimplication. Continuous monitoring ofsurfacewaters
is vital to identify potential water-borne pathogens and to
reduce the health risk caused by the Aeromonads.
12. Conclusion
Aeromonas infection remains among those infectious dis-
easesofpotentiallyseriousthreattopublichealth.Aeromonas
diseaseoutbreakshavecreatedapainfulawarenessoftheper-
sonal, economic, societal, and public health costs associated
with the impact of contaminated water in the aquatic milieu.
ThereisevidencetosuggestthattheprevalenceofAeromonas
infectionsmaybedramaticallyunderestimatedindeveloping
nations and that routine endemic exposure to waterborne
and food-borne pathogens may occur more frequently than
originally perceived. A variety of demographical, societal,
environmental, and physiological emergence factors likely
play critical roles in enhancing the frequency of transmission
of pathogens to hosts and the increasing trend in antibiotics
resistance in the bacteria makes extended studies on the
bacteria imperative and this is subject of investigation in our
group.
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